Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® ( Solriamfetol ) Patent Litigation with Sandoz Inc.

4 weeks ago

NEW YORK, Aug. 21, 2024 ( GLOBE NEWSWIRE ) -- Axsome Therapeutics, Inc. ( NASDAQ: AXSM ) , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced that it has reached agreement with Sandoz Inc. ( Sandoz ) to ...

Ticker	Sentiment	Impact
AXSM	Neutral	16 %